Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1801 1
1805 1
1928 1
1937 2
1939 1
1941 1
1945 3
1946 14
1947 12
1948 16
1949 11
1950 21
1951 11
1952 11
1953 21
1954 27
1955 51
1956 20
1957 23
1958 30
1959 15
1960 17
1961 18
1962 27
1963 34
1964 29
1965 17
1966 38
1967 33
1968 27
1969 30
1970 28
1971 35
1972 45
1973 25
1974 38
1975 30
1976 30
1977 36
1978 43
1979 42
1980 52
1981 31
1982 35
1983 34
1984 33
1985 39
1986 43
1987 30
1988 44
1989 54
1990 53
1991 38
1992 43
1993 43
1994 51
1995 45
1996 48
1997 42
1998 53
1999 41
2000 53
2001 65
2002 58
2003 55
2004 80
2005 74
2006 89
2007 81
2008 100
2009 90
2010 112
2011 128
2012 122
2013 139
2014 146
2015 178
2016 197
2017 153
2018 169
2019 164
2020 184
2021 124
Text availability
Article attribute
Article type
Publication date

Search Results

4,083 results
Results by year
Filters applied: . Clear all
Page 1
An evidence review of face masks against COVID-19.
Howard J, Huang A, Li Z, Tufekci Z, Zdimal V, van der Westhuizen HM, von Delft A, Price A, Fridman L, Tang LH, Tang V, Watson GL, Bax CE, Shaikh R, Questier F, Hernandez D, Chu LF, Ramirez CM, Rimoin AW. Howard J, et al. Proc Natl Acad Sci U S A. 2021 Jan 26;118(4):e2014564118. doi: 10.1073/pnas.2014564118. Proc Natl Acad Sci U S A. 2021. PMID: 33431650 Free PMC article. Review.
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.
Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, Hassab H, Achebe MM, Alkindi S, Brown RC, Diuguid DL, Telfer P, Tsitsikas DA, Elghandour A, Gordeuk VR, Kanter J, Abboud MR, Lehrer-Graiwer J, Tonda M, Intondi A, Tong B, Howard J; HOPE Trial Investigators. Vichinsky E, et al. Among authors: howard j. N Engl J Med. 2019 Aug 8;381(6):509-519. doi: 10.1056/NEJMoa1903212. Epub 2019 Jun 14. N Engl J Med. 2019. PMID: 31199090 Clinical Trial.
Neutrophil extracellular traps target senescent vasculature for tissue remodeling in retinopathy.
Binet F, Cagnone G, Crespo-Garcia S, Hata M, Neault M, Dejda A, Wilson AM, Buscarlet M, Mawambo GT, Howard JP, Diaz-Marin R, Parinot C, Guber V, Pilon F, Juneau R, Laflamme R, Sawchyn C, Boulay K, Leclerc S, Abu-Thuraia A, Côté JF, Andelfinger G, Rezende FA, Sennlaub F, Joyal JS, Mallette FA, Sapieha P. Binet F, et al. Among authors: howard jp. Science. 2020 Aug 21;369(6506):eaay5356. doi: 10.1126/science.aay5356. Science. 2020. PMID: 32820093
Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.
International MG/COVID-19 Working Group, Jacob S, Muppidi S, Guidon A, Guptill J, Hehir M, Howard JF Jr, Illa I, Mantegazza R, Murai H, Utsugisawa K, Vissing J, Wiendl H, Nowak RJ. International MG/COVID-19 Working Group, et al. Among authors: howard jf jr. J Neurol Sci. 2020 May 15;412:116803. doi: 10.1016/j.jns.2020.116803. Epub 2020 Mar 25. J Neurol Sci. 2020. PMID: 32247193 Free PMC article. No abstract available.
N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects.
Wood FA, Howard JP, Finegold JA, Nowbar AN, Thompson DM, Arnold AD, Rajkumar CA, Connolly S, Cegla J, Stride C, Sever P, Norton C, Thom SAM, Shun-Shin MJ, Francis DP. Wood FA, et al. Among authors: howard jp. N Engl J Med. 2020 Nov 26;383(22):2182-2184. doi: 10.1056/NEJMc2031173. Epub 2020 Nov 15. N Engl J Med. 2020. PMID: 33196154 Clinical Trial. No abstract available.
COVID-19-associated risks and effects in myasthenia gravis (CARE-MG).
Muppidi S, Guptill JT, Jacob S, Li Y, Farrugia ME, Guidon AC, Tavee JO, Kaminski H, Howard JF Jr, Cutter G, Wiendl H, Maas MB, Illa I, Mantegazza R, Murai H, Utsugisawa K, Nowak RJ; CARE-MG Study Group. Muppidi S, et al. Among authors: howard jf jr. Lancet Neurol. 2020 Dec;19(12):970-971. doi: 10.1016/S1474-4422(20)30413-0. Lancet Neurol. 2020. PMID: 33212055 Free PMC article. No abstract available.
Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis.
Howard JF Jr, Bril V, Burns TM, Mantegazza R, Bilinska M, Szczudlik A, Beydoun S, Garrido FJRR, Piehl F, Rottoli M, Van Damme P, Vu T, Evoli A, Freimer M, Mozaffar T, Ward ES, Dreier T, Ulrichts P, Verschueren K, Guglietta A, de Haard H, Leupin N, Verschuuren JJGM; Efgartigimod MG Study Group. Howard JF Jr, et al. Neurology. 2019 Jun 4;92(23):e2661-e2673. doi: 10.1212/WNL.0000000000007600. Epub 2019 May 22. Neurology. 2019. PMID: 31118245 Free PMC article. Clinical Trial.
Complement Inhibitor Therapy for Myasthenia Gravis.
Albazli K, Kaminski HJ, Howard JF Jr. Albazli K, et al. Among authors: howard jf jr. Front Immunol. 2020 Jun 3;11:917. doi: 10.3389/fimmu.2020.00917. eCollection 2020. Front Immunol. 2020. PMID: 32582144 Free PMC article. Review.
4,083 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page